News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Onsite 340B And ARKRAY USA Ink Deal To Help Covered Entities Improve Outcomes For At-Risk Population With Diabetes



7/20/2017 10:14:44 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs

KENNETT SQUARE, Pa., July 20, 2017 /PRNewswire/ -- Onsite 340B and ARKRAY USA announced today they are cooperating to help improve the health services for qualifying 340B program patients with diabetes. Under the terms of the agreement, ARKRAY glucose meters and diabetes wellness toolkits are now available free of charge at Onsite 340B dispensaries. In addition, they provide the lowest-cost diabetes test strips and insulin pen needles available as per the HRSA 340B contract.

Onsite is the first full-service solution enabling doctors at 340B Covered Entities to directly provide the medications they prescribe, at a significant discount, to their patients at the clinic, their home and in the field. ARKRAY USA develops innovative diagnostic and monitoring products for diabetes care.

"We are proud to partner with ARKRAY USA to help improve the outcomes for the patients with diabetes treated at 340B Covered Entities.  Our partnership will enable Covered Entities with Onsite 340B dispensaries to improve patient care and patient compliance amongst the at-risk population with diabetes. In addition, it will provide these Covered Entities a cost savings that can be infused into their stretched budgets to provide continued support for existing programs or to establish new ones to better service the community," said Kate Martin, CEO of Onsite 340B.

"Our mission is to contribute to the health and well-being of people all over the world through the advancement of science and the discovery of new technology. In partnering with Onsite 340B, we are able to help providers deliver a more robust diabetes management plan for those who would otherwise be unable to get the quality care they need," said Jonathan Chapman, President of ARKRAY USA.

About ARKRAY USA

ARKRAY has devoted more than half a century to creating solutions that simplify the lives of people with diabetes and the health professionals who care for them. Their expertise and personalized approach to diabetes management help empower people to live richer, healthier lives.  For healthcare providers, this means access to cutting edge and reliable products combined with superior customer support. With products and programs that reach throughout the industry, ARKRAY has become the trusted source across the healthcare continuum.

ARKRAY provides the lowest-cost test strips and insulin pen needles on the 340B contract, plus provides blood glucose meters at no charge. They bundle these products with educational materials for better diabetes management and continuing education courses to providers at no cost. This additional benefit is of great appeal to providers as they no longer have to utilize their funding for these much needed tools and training.

For more information, please visit www.arkrayusa.com

About Onsite 340B

Onsite 340B solutions and services maximize 340B Program benefits and savings to non-profit, federally qualified health centers (FQHCs) or "Covered Entities", without the funding to open and operate an in-house pharmacy.  Onsite 340B enables Covered Entities to provide discounted medications from their Onsite 340B Dispensary to its patients, in a one-stop shopping environment doctor visit and prescription fill. The savings generated from dispensing discounted medications on site enable Covered Entities to further stretch limited budgets and expand services and reach to the community. The Onsite 340B solution gives the Covered Entity full control over their program: no spilt billing is required, the risks of diversion and duplicate discounts are virtually eliminated, and medications are pre-packaged in unit of use containers. ALL this at no extra cost to the state or the Medicaid program.

To learn how Onsite 340B can help your facility better navigate this complex market and obtain cost savings please visit www.Onsite340B.com.

To schedule an introductory appointment, please reach out to Buzz Hannum, Director, Business Development, at RHannum@Onsite340B.com or at (855) 355-340B.

Like us on Facebook. Follow us on LinkedIn and Twitter.

 

 

View original content:http://www.prnewswire.com/news-releases/onsite-340b-and-arkray-usa-ink-deal-to-help-covered-entities-improve-outcomes-for-at-risk-population-with-diabetes-300491647.html

SOURCE ARKRAY USA


Read at BioSpace.com


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES